| No. of studies | OR | 95%CI | p | Heterogeneity (I2) (%) |
---|---|---|---|---|---|
Type of CS | |||||
 Elective CS | 13 | 1.18 | 1.11–1.25 |  < 0.001 | 71.4 |
 Emergency CS | 13 | 1.18 | 1.10–1.27 |  < 0.001 | 83.3 |
Sex | |||||
 Female | 3 | 1.26 | 1.13–1.42 |  < 0.001 | 0 |
 Male | 3 | 1.07 | 0.94–1.22 | 0.325 | 0 |
Continent | |||||
 Asia | 4 | 1.17 | 0.97–1.42 | 0.102 | 81.3 |
 Europe | 23 | 1.20 | 1.15–1.26 |  < 0.001 | 70.4 |
 North America | 5 | 1.15 | 1.11–1.19 |  < 0.001 | 0 |
 Oceania | 3 | 1.06 | 1.02–1.11 | 0.008 | 0 |
Atopic asthma | 6 | 1.14 | 1.11–1.18 |  < 0.001 | 0 |
Persistent asthma | 3 | 1.15 | 0.99–1.33 | 0.063 | 65.3 |
Cohort design | |||||
 Prospective cohort | 13 | 1.19 | 1.11–1.28 |  < 0.001 | 40.4 |
 Retrospective cohort | 22 | 1.17 | 1.11–1.23 |  < 0.001 | 86.9 |